• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

SARS-CoV-2 Spillback to Wild Coatis in Sylvatic–Urban Hotspot, Brazil - CDC

Mary Wilson

Well-known member
February 15, 2023

https://doi.org/10.3201/eid2903.221339

Ana Gabriella Stoffella-Dutra, Bruna Hermine de Campos, Pedro Henrique Bastos e Silva, Karolina Lopes Dias, Iago José da Silva Domingos, Nadja Simbera Hemetrio, Joilson Xavier, Felipe Iani, Vagner Fonseca, Marta Giovanetti, Leonardo Camilo de Oliveira, Mauro Martins Teixeira, Zelia Ines Portela Lobato, Helena Lage Ferreira, Clarice Weis Arns, Edison Durigon, Betânia Paiva Drumond, Luiz Carlos Junior Alcantara, Marcelo Pires Nogueira de Carvalho, and Giliane de Souza Trindade

Abstract

We tested coatis (Nasua nasua) living in an urban park near a densely populated area of Brazil and found natural SARS-CoV-2 Zeta variant infections by using quantitative reverse transcription PCR, genomic sequencing, and serologic surveillance. We recommend a One Health strategy to improve surveillance of and response to COVID-19.

https://wwwnc.cdc.gov/eid/article/29/3/22-1339_article
 
Back
Top